Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
NEO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.46

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

0.11

EPS Last/This Y

1.02

EPS This/Next Y

0.18

Price

9.23

Target Price

15.06

Analyst Recom

1.67

Performance Q

-7.42

Upside

-392.0%

Beta

1.79

Ticker: NEO




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23NEO7.920.130.0010992
2026-04-24NEO8.30.130.0010993
2026-04-27NEO8.620.130.1111022
2026-04-28NEO9.020.150.0411218
2026-04-29NEO8.970.160.1210967
2026-04-30NEO9.270.160.1611052
2026-05-01NEO9.440.160.1211072
2026-05-04NEO8.990.160.0611063
2026-05-05NEO8.850.160.0811070
2026-05-06NEO8.890.163.8011047
2026-05-07NEO9.070.160.2911062
2026-05-08NEO8.970.160.0011061
2026-05-11NEO8.650.160.1111070
2026-05-12NEO8.760.160.0011069
2026-05-13NEO8.270.160.1211037
2026-05-14NEO8.360.160.0011073
2026-05-15NEO8.230.150.0311082
2026-05-18NEO8.360.110.005984
2026-05-19NEO8.390.110.045991
2026-05-20NEO8.90.110.006102
2026-05-21NEO9.110.110.006412
2026-05-22NEO9.220.100.016509
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23NEO7.910.0- 0.15
2026-04-24NEO8.290.0- 0.15
2026-04-27NEO8.620.0- 0.15
2026-04-28NEO9.030.0- 0.15
2026-04-30NEO9.270.0- 0.15
2026-05-01NEO9.440.0- 0.17
2026-05-04NEO8.993.7- 0.17
2026-05-05NEO8.853.7- 0.18
2026-05-06NEO8.893.7- 0.18
2026-05-07NEO9.073.7- 0.18
2026-05-08NEO8.973.7- 0.18
2026-05-11NEO8.6512.1- 0.18
2026-05-12NEO8.7612.1- 0.18
2026-05-13NEO8.2612.1- 0.18
2026-05-14NEO8.3512.1- 0.18
2026-05-15NEO8.2412.1- 0.18
2026-05-18NEO8.3612.1- 0.18
2026-05-19NEO8.3812.1- 0.18
2026-05-20NEO8.8912.1- 0.18
2026-05-21NEO9.1112.1- 0.18
2026-05-22NEO9.2312.1- 0.18
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23NEO-1.856.565.97
2026-04-24NEO-1.846.565.95
2026-04-27NEO-1.846.366.17
2026-04-28NEO-1.846.366.17
2026-04-29NEO-1.846.366.17
2026-04-30NEO-1.846.366.17
2026-05-01NEO-1.846.366.16
2026-05-04NEO-1.846.226.16
2026-05-05NEO-1.846.226.16
2026-05-06NEO-1.846.226.16
2026-05-07NEO-1.846.226.16
2026-05-08NEO-1.846.226.16
2026-05-11NEO-1.8410.476.16
2026-05-12NEO-1.8410.477.46
2026-05-13NEO-1.8610.477.46
2026-05-14NEO-1.8610.477.46
2026-05-15NEO-1.8610.477.46
2026-05-18NEO-1.8614.387.46
2026-05-19NEO-1.8714.387.46
2026-05-20NEO-1.8714.387.46
2026-05-21NEO-1.8714.387.46
2026-05-22NEO-1.8714.387.46
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

0.03

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

-1.87

Institutional Transactions

14.38

Beta

1.79

Average Sales Estimate Current Quarter

196

Average Sales Estimate Next Quarter

205

Fair Value

Quality Score

43

Growth Score

43

Sentiment Score

97

Actual DrawDown %

83.2

Max Drawdown 5-Year %

-90.8

Target Price

15.06

P/E

Forward P/E

25.32

PEG

0.41

P/S

1.61

P/B

1.44

P/Free Cash Flow

EPS

-0.77

Average EPS Est. Cur. Y​

0.18

EPS Next Y. (Est.)

0.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-13.3

Relative Volume

0.4

Return on Equity vs Sector %

-39

Return on Equity vs Industry %

-22.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

NEO Healthcare
$9.23
📉
Swing / Pullback
Buy the dip on strong trends
59 /100
WATCH
Trend
14/20
Pullback
6/25
Volume
11/15
Valuation
15/20
TP/AR
5/10
Options
8/10
RSI
60.1
Range 1M
57.6%
Sup Dist
5.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
53 /100
WEAK
Momentum
7/25
Growth
24/30
Estimates
8/20
Inst/Vol
6/15
Options
8/10
EPS Yr
50%
EPS NY
102.5%
52W%
49.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +44.1% upside
Quality
5/30
Valuation
15/30
Growth
19/25
Stability
8/10
LT Trend
1/5
Upside
+44.1%
Quality
43
NeoGenomics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2500
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
NEO

Latest News

Caricamento notizie per NEO
stock quote shares NEO – Neogenomics Inc. Stock Price stock today
news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – Neogenomics Inc. yahoo finance google finance
stock history NEO – Neogenomics Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading